6:32 PM
 | 
Jun 06, 2008
 |  BC Extra  |  Company News

FDA panel to review tolvaptan

FDA's Cardiovascular and Renal Drugs Advisory Committee will meet on June 25 to review an...

Read the full 52 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >